CVE-2023-37613
MEDIUMCVSS 6.1/10EPSS 0.38%
Last modified
CVE-2023-37613 is a medium-severity vulnerability rated 6.1/10 on the CVSS scale. A cross-site scripting (XSS) vulnerability in Assembly Software Trialworks v11.4 allows attackers to execute arbitrary web scripts or HTML via injecting a crafted payload into the asset src parameter.. EPSS estimates a 0.38% chance of exploitation in the next 30 days.
Description
A cross-site scripting (XSS) vulnerability in Assembly Software Trialworks v11.4 allows attackers to execute arbitrary web scripts or HTML via injecting a crafted payload into the asset src parameter.
Metrics
CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:L/I:L/A:N
Weakness Enumeration
Affected Software
| Vendor | Product | Versions |
|---|---|---|
| Assemblysoftware | Trialworks | 11.4 |
References
- https://github.com/HeidiSecurities/CVEs/blob/main/CVE-2023-37613/Trialworks.mdExploit, Third Party Advisory
- https://github.com/HeidiSecurities/CVEs/blob/main/CVE-2023-37613/Trialworks.mdExploit, Third Party Advisory
Timeline
- Published
- Last Modified
- Status
- Modified
Frequently Asked Questions
What is CVE-2023-37613?
A cross-site scripting (XSS) vulnerability in Assembly Software Trialworks v11.4 allows attackers to execute arbitrary web scripts or HTML via injecting a crafted payload into the asset src parameter.
How severe is CVE-2023-37613?
CVE-2023-37613 has a CVSS score of 6.1/10 (MEDIUM severity). The EPSS model estimates a 0.38% probability of exploitation in the next 30 days.
How do I fix CVE-2023-37613?
Check the vendor references and advisories linked above for patched versions and mitigation guidance. You can also run a Strix scan to test if your systems are affected.
Are you affected by CVE-2023-37613?
Run a free Strix scan to check your systems for this vulnerability.
Scan your code nowSource: NVD / NIST